<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">(%) </span>
   <span class="font18">coronavirus </span>
   <span class="font18">MERS </span>
   <span class="font17">study </span>
   <span class="font17">participants </span>
   <span class="font15">responses </span>
   <span class="font14">GLS- </span>
   <span class="font14">vaccine </span>
   <span class="font13">week </span>
   <span class="font12">East </span>
   <span class="font12">Life </span>
   <span class="font12">reports </span>
   <span class="font12">DNA </span>
   <span class="font12">GeneOne </span>
   <span class="font12">dose </span>
   <span class="font12">respiratory </span>
   <span class="font12">reported </span>
   <span class="font12">{border-style </span>
   <span class="font12">antibodies </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">Middle </span>
   <span class="font12">adverse </span>
   <span class="font12">clinical </span>
   <span class="font12">data </span>
   <span class="font12">phase </span>
   <span class="font12">syndrome </span>
   <span class="font11">antibody </span>
   <span class="font11">blood </span>
   <span class="font11">infection </span>
   <span class="font11">cellular </span>
   <span class="font11">neutralising </span>
   <span class="font11">samples </span>
   <span class="font11">Science. </span>
   <span class="font11">grants </span>
   <span class="font11">mean </span>
   <span class="font11">trial </span>
   <span class="font11">vaccination </span>
   <span class="font11">T-cell </span>
   <span class="font11">[%] </span>
   <span class="font11">mg, </span>
   <span class="font11">peripheral </span>
   <span class="font11">(appendix </span>
   <span class="font11">Army </span>
   <span class="font11">S-ELISA </span>
   <span class="font11">events </span>
   <span class="font11">following </span>
   <span class="font11">group </span>
   <span class="font11">mononuclear </span>
   <span class="font11">CCR, </span>
   <span class="font11">CR, </span>
   <span class="font11">binding </span>
   <span class="font11">site </span>
   <span class="font11">treatment </span>
   <span class="font11">vaccines </span>
   <span class="font11">(figure </span>
   <span class="font11">analysis </span>
   <span class="font11">appendix </span>
   <span class="font11">enrolled </span>
   <span class="font11">full-length </span>
   <span class="font11">immune </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">infection. </span>
   <span class="font11">related </span>
   <span class="font11">safety </span>
   <span class="font11">Department </span>
   <span class="font11">Institute </span>
   <span class="font11">MJ, </span>
   <span class="font11">South </span>
   <span class="font11">available </span>
   <span class="font11">cells </span>
   <span class="font11">collected </span>
   <span class="font11">convalescent </span>
   <span class="font11">fees </span>
   <span class="font11">laboratory </span>
   <span class="font11">personal </span>
   <span class="font11">px; </span>
   <span class="font11">weeks </span>
   <span class="font11">{font-family </span>
   <span class="font10">(n=) </span>
   <span class="font10">(·%) </span>
   <span class="font10">(·) </span>
   <span class="font10">administration </span>
   <span class="font10">assessed </span>
   <span class="font10">common </span>
   <span class="font10">detected </span>
   <span class="font10">font-size </span>
   <span class="font10">groups </span>
   <span class="font10">included </span>
   <span class="font10">individuals </span>
   <span class="font10">lower </span>
   <span class="font10">measured </span>
   <span class="font10">natural </span>
   <span class="font10">provided </span>
   <span class="font10">response </span>
   <span class="font10">DK, </span>
   <span class="font10">HL, </span>
   <span class="font10">Infect </span>
   <span class="font10">KMo, </span>
   <span class="font10">Reed </span>
   <span class="font10">SBK, </span>
   <span class="font10">Walter </span>
   <span class="font10">YKP, </span>
   <span class="font10">acute </span>
   <span class="font10">cells. </span>
   <span class="font10">disease </span>
   <span class="font10">double; </span>
   <span class="font10">endpoint </span>
   <span class="font10">geometric </span>
   <span class="font10">higher </span>
   <span class="font10">humoral </span>
   <span class="font10">including </span>
   <span class="font10">induced </span>
   <span class="font10">infected </span>
   <span class="font10">injection </span>
   <span class="font10">intramuscular </span>
   <span class="font10">modified </span>
   <span class="font10">potential </span>
   <span class="font10">previous </span>
   <span class="font10">solicited </span>
   <span class="font10">titres </span>
   <span class="font10">use </span>
   <span class="font10">(MERS) </span>
   <span class="font10">Clinical </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Inovio </span>
   <span class="font10">Research </span>
   <span class="font10">S-glycoprotein </span>
   <span class="font10">Science </span>
   <span class="font10">Vero </span>
   <span class="font10">abnormalities </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cases </span>
   <span class="font10">collab: </span>
   <span class="font10">cytokine </span>
   <span class="font10">designed </span>
   <span class="font10">did </span>
   <span class="font10">dose-escalation </span>
   <span class="font10">efficacy </span>
   <span class="font10">future </span>
   <span class="font10">grade </span>
   <span class="font10">group, </span>
   <span class="font10">healthy </span>
   <span class="font10">human </span>
   <span class="font10">infections </span>
   <span class="font10">months </span>
   <span class="font10">patients </span>
   <span class="font10">previously </span>
   <span class="font10">protein </span>
   <span class="font10">report </span>
   <span class="font10">reviewed </span>
   <span class="font10">showed </span>
   <span class="font10">significant </span>
   <span class="font10">solid; </span>
   <span class="font10">symptom </span>
   <span class="font10">symptoms </span>
   <span class="font10">test </span>
   <span class="font10">testing </span>
   <span class="font10">treatment. </span>
   <span class="font10">units </span>
   <span class="font10">used </span>
   <span class="font10">using </span>
   <span class="font10">vaccination. </span>
   <span class="font10">viral </span>
   <span class="font10">virus </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(%), </span>
   <span class="font10">COVID- </span>
   <span class="font10">Dis </span>
   <span class="font10">EMC- </span>
   <span class="font10">JB, </span>
   <span class="font10">JNM </span>
   <span class="font10">JNM, </span>
   <span class="font10">Korea </span>
   <span class="font10">Korean </span>
   <span class="font10">MCW, </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">NLM, </span>
   <span class="font10">Pharmaceuticals </span>
   <span class="font10">SJT, </span>
   <span class="font10">SW, </span>
   <span class="font10">Serum </span>
   <span class="font10">ability </span>
   <span class="font10">additional </span>
   <span class="font10">analysed </span>
   <span class="font10">approved </span>
   <span class="font10">baseline </span>
   <span class="font10">bold </span>
   <span class="font10">centre </span>
   <span class="font10">collection </span>
   <span class="font10">consent </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">creatine </span>
   <span class="font10">deemed </span>
   <span class="font10">electroporation </span>
   <span class="font10">em; </span>
   <span class="font10">employees </span>
   <span class="font10">evidence </span>
   <span class="font10">final </span>
   <span class="font10">followed </span>
   <span class="font10">group. </span>
   <span class="font10">immunogenic </span>
   <span class="font10">information </span>
   <span class="font10">maintained </span>
   <span class="font10">million </span>
   <span class="font10">naturally </span>
   <span class="font10">non-human </span>
   <span class="font10">novel </span>
   <span class="font10">occurred </span>
   <span class="font10">outbreak </span>
   <span class="font10">outcome </span>
   <span class="font10">participant </span>
   <span class="font10">pending </span>
   <span class="font10">peptide </span>
   <span class="font10">planned </span>
   <span class="font10">possibly </span>
   <span class="font10">primary </span>
   <span class="font10">protocol </span>
   <span class="font10">pt;} </span>
   <span class="font10">reactions </span>
   <span class="font10">received </span>
   <span class="font10">recovered </span>
   <span class="font10">resource </span>
   <span class="font10">safety, </span>
   <span class="font10">sample </span>
   <span class="font10">screening </span>
   <span class="font10">serum </span>
   <span class="font10">shows </span>
   <span class="font10">similar </span>
   <span class="font10">single </span>
   <span class="font10">spike </span>
   <span class="font10">spot-forming </span>
   <span class="font10">staining </span>
   <span class="font10">statistical </span>
   <span class="font10">studies </span>
   <span class="font10">study. </span>
   <span class="font10">support </span>
   <span class="font10">synthetic </span>
   <span class="font10">systemic </span>
   <span class="font10">tract </span>
   <span class="font10">trials </span>
   <span class="font10">year </span>
  </p>
 </body>
</html>
